Why BGPT?
logo

Evidence Paper Review

Analyze how experimental results and claims are presented, scoped, and limited in a paper.Know what the science actually supports before you trust the answer.

Press Enter ↡ to analyze



    Explore by Goal












     Quick Explanation


    Core result
    In NIH 3T3 cells treated with forskolin, the paper concludes that PKA is the dominant driver of CREB Ser-133 phosphorylation during the early β€œburst” phase, while a time-delayed, PKA-dependent p38β†’MSK1 relay sustains/boosts CREB-mediated transcriptional output.



     Long Explanation


    Paper review (science-first): cAMP β†’ CREB via PKA + delayed p38/MSK1 in NIH 3T3

    Target paper: Delghandi et al., 2005, Cellular Signalling (DOI: 10.1016/j.cellsig.2005.02.003).

    What the paper claims (structure-level)

    • Early: Forskolin-induced CREB Ser-133 phosphorylation is largely PKA-dependent (H89 abrogates phospho-CREB and CREB-driven transcription).
    • Branch 2 (relay): Forskolin increases p38 phosphorylation in a PKA-dependent way (H89 reduces it), and the kinetics are delayed relative to PKA activity and early CREB phosphorylation.
    • Functional output: Activated p38 potentiates CREB-dependent transcription; the p38β†’CREB arm is mediated through MSK1, not MSK2/RSK-B (dominant-negative MSK1 mutants reduce p38-driven CREB transcription; dnMSK2/RSK-B and MAPKAPK2 mutants do not interfere with forskolin-driven CREB reporter activation, per authors’ results).
    • Proposed logic: A bifurcated signaling architecture (early PKAβ†’CREB plus delayed PKA-dependent p38β†’MSK1β†’CREB) may help sustain transcriptional responses even as initial PKA output attenuates.

    Visual 1 β€” pathway map (evidence-weighted edges)

    Key experimental strategies used

    Strategy Purpose in this paper Main readouts
    Pharmacological kinase inhibition Disentangle which cAMP-activated kinase(s) mediate phospho-CREB and CREB transcription Western blot phospho-CREB (Ser-133), CREB reporter (GAL4-CREB→luciferase)
    Western blot time series Compare timing (PKA burst vs delayed p38 phosphorylation) phospho-p38 across minutes after forskolin
    Transient transfection + reporter assays Test whether pathway components (p38, MSK1) can causally enhance CREB transcriptional activity GAL4-CREB luciferase; co-expression of constitutively active upstream kinase (MKK6E/E)
    Dominant-negative constructs Assign causality to MSK1 vs MSK2/RSK-B and MAPKAPK2 Suppression of p38-induced CREB reporter activation

    Figure correspondence (from the paper text you provided)

    • Fig. 1: H89 (PKA inhibitor) blocks forskolin-induced phospho-CREB (Ser-133) and CREB-driven luciferase; other tested inhibitors do not significantly block phospho-CREB under those conditions.
    • Fig. 2: Epac activator fails to induce CREB phosphorylation or CREB reporter activation (argues against Epacβ†’CREB in this context).
    • Fig. 3: Forskolin phosphorylates p38 (not ERK1/2 or ERK5), and H89 reduces p38 phosphorylation, supporting PKA-dependent p38 activation.
    • Fig. 4: p38 activation potentiates CREB reporter transcription, including forskolin- and PKA-induced CREB activity (suggesting p38 acts as a transcriptional amplifier when engaged).
    • Fig. 5: MSK1 is required for p38-mediated CREB reporter activation; dominant-negative MSK1 mutants reduce p38-driven CREB transcription, and H89 reduces it further in the p38-activated context.
    • Fig. 6: phospho-p38 kinetics after forskolin; p38 phosphorylation is detectable by 30 min and remains elevated through at least 120 min (supporting delay/sustain model).
    Important limitation of this review: the provided full text contains figure legends and qualitative timing, but not the underlying densitometry numeric values, so the visualizations below avoid making up quantitative series.

    Critical assessment (skeptical, mechanistic, and bias-aware)

    1) Specificity of inhibitors and the H89 β€œdouble hit” issue
    The paper uses H89 as the key PKA inhibitor, but it also reports that H89 inhibits MSK1 kinase activity as well (as stated in the text when confirming MSK1 involvement).
    Why this matters: When H89 blocks both phospho-CREB and p38β†’CREB transcriptional potency, causality remains plausible, but the inhibitory phenotype could reflect combined suppression of PKA and MSK1 rather than clean sequential wiring.
    2) Evidence for β€œPKA burst β†’ attenuation β†’ delayed p38 relay” is suggestive, not directly measured for PKA activity here
    The paper discusses a known PKA β€œburst-attenuation-refractory” behavior and states that PKA activity drops faster than phospho-CREB, then argues delayed p38 sustains CREB phosphorylation. However, within the excerpt you provided, the direct quantified PKA activity time series in this exact experimental run is not shown; the text references previous work for PKA kinetics.
    Consequence: the relay narrative is coherent, but the strongest falsification would be to repeat experiments measuring PKA activity and phospho-CREB/phospho-p38 simultaneously with matched sampling and conditions.
    3) Translating phosphorylation to transcriptional outcomes: reporter context caveats
    The transcriptional readout is a GAL4-CREB luciferase reporter system. This is standard for mapping CREB transactivation capacity, but it is not the same as testing endogenous target genes, nor does it ensure the same chromatin context, CREB coactivator availability (CBP/p300), or promoter architecture.
    4) Missing β€œdephosphorylation/turnover” layer in the relay argument
    Sustained CREB Ser-133 phosphorylation depends not only on kinase input, but also on phosphatases. A classic CREB attenuation mechanism involves protein phosphatase-1 (PP-1) mediating dephosphorylation after cAMP induction.
    The Delghandi et al. paper focuses heavily on kinase-side wiring; it does not (in the provided text) directly test whether the delayed p38β†’MSK1 effect alters phosphatase engagement or whether PP-1-mediated attenuation is concurrently modulated.

    Confidence map: what is strong vs uncertain (from the provided full text)

    • Strong: H89’s ability to abrogate phospho-CREB (Ser-133) and CREB-driven reporter induction following forskolin, within the experimental window described.
    • Moderate: p38 phosphorylation occurs and is reduced by H89 (supporting PKA dependence), with delayed kinetics consistent with the relay model.
    • Moderate: MSK1 is functionally required for p38-mediated CREB transcriptional potency in their reporter framework.
    • Uncertain / needs direct remeasurement: the mechanistic chain β€œPKA burst attenuates while p38 remains elevated and thereby sustains phospho-CREB” is supported by cross-referenced kinetics and the presented p38 series, but would be stronger with simultaneous PKA activity measurements in the same experimental batch.

    Where this fits the wider cAMP/CREB logic (tight, evidence-based)

    Phosphatase counterbalance: CREB Ser-133 phosphorylation and transcriptional attenuation can be governed by phosphatases like PP-1 following cAMP induction.
    cAMP compartmentalization caveat: cAMP signaling is spatially structured in cells (e.g., soluble adenylyl cyclase creating local microdomains), meaning β€œglobal cAMP elevation” by forskolin may not map to uniform intracellular signaling for CREB regulators.

    Actionable β€œwhat would disprove or refine it?”

    • Direct simultaneous kinetics: measure (i) PKA activity, (ii) phospho-CREB (Ser-133), and (iii) phospho-p38 in matched timepoints from the same forskolin stimulation batch to test the claimed burst vs delayed relay ordering.
    • Separate inhibitor vs kinase requirements: use MSK1-specific perturbation that is not pharmacologically overlapping with PKA to reduce confounding from H89’s dual inhibition (as noted by the authors).
    • Endogenous target validation: check endogenous CREB targets (not just GAL4-CREB reporter) to ensure promoter/chromatin context doesn’t alter pathway ranking.


    Feedback:    

    Updated: April 02, 2026

     BGPT Paper Review


    Study Novelty

    70%

    The paper refines an established cAMP→CREB concept by proposing a specific, cell-context bifurcation (early PKA dominance + delayed PKA-dependent p38→MSK1 relay) with kinase-perturbation evidence in NIH 3T3 cells. This is incremental but mechanistically specific.


    Scientific Quality

    80%

    Strengths include coherent inhibitor/dominant-negative logic, phospho-readout plus transcriptional reporter support, and a time-course argument. Main quality limitations: reliance on H89 (not perfectly pathway-specific, with MSK1 inhibition acknowledged by the authors) and reporter-based transcriptional inference rather than endogenous gene validation.


    Study Generality

    60%

    Mechanistic wiring is demonstrated in a single model cell line (NIH 3T3 fibroblasts) and under forskolin stimulation. The relay logic may generalize to other contexts, but the paper itself emphasizes cell-type specificity (and notes discrepancies across labs/cell lines), lowering generality.


    Study Usefulness

    70%

    Useful as a mechanistic hypothesis generator for how cAMP signals can be temporally shaped to sustain CREB activity, especially relevant for designing follow-up experiments involving MSK1/p38 kinetics and PKA attenuation.


    Study Reproducibility

    70%

    Methods describe standard Western/reporters and inhibitor usage, but the excerpt doesn’t include raw numeric densitometry values or full statistical tables; also reliance on H89 specificity and transient overexpression/dominant-negative strategies can affect reproducibility across labs.


    Explanatory Depth

    70%

    Mechanistic explanation is relatively deep for kinase-pathway routing and timing (relay logic). However, it is less deep on how kinetics are generated mechanistically (e.g., upstream mechanism of PKA→p38, phosphatase counter-regulation, compartmentalization effects), which the paper acknowledges as remaining elusive.


    🎁 Authors: Collect 230 Free Science Tokens (β‰ˆ $23.0 USD)

    Claim My Author Tokens

    Use for 57 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $23.0 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    Extract figure-legends and any quantitative fold-change/timepoint values from the full text, build a causality decision graph, and generate Plotly pathway-timing visuals constrained to provided numbers only.



     Hypothesis Graveyard


    The hypothesis that Epac is the primary route from forskolin to CREB activation in NIH 3T3 is disfavored by the paper’s Epac activator negative results under the tested conditions.


    The idea that ERK1/2 or ERK5 are major contributors to forskolin-induced CREB phosphorylation in NIH 3T3 is undermined by the lack of observed ERK phosphorylation/activation after forskolin and the authors’ inhibitor-related findings.

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending